quinuclidines has been researched along with Osteosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lai, J; Li, C; Li, P; Li, Y; Li, Z; Rastogi, S | 1 |
Bergman, J; Bykov, VJ; Selivanova, G; Stridh, H; Westman, J; Wiman, KG; Zache, N | 1 |
1 trial(s) available for quinuclidines and Osteosarcoma
Article | Year |
---|---|
Does a single dose of palonosetron have any role in preventing acute chemotherapy-induced nausea and vomiting in pediatric osteosarcoma patients without dexamethasone? A randomized clinical trial.
Topics: Antineoplastic Agents; Child; Dexamethasone; Humans; Isoquinolines; Nausea; Osteosarcoma; Palonosetron; Quinuclidines; Vomiting | 2022 |
1 other study(ies) available for quinuclidines and Osteosarcoma
Article | Year |
---|---|
PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis.
Topics: Adenocarcinoma; Animals; Apoptosis; Aza Compounds; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Interactions; Drug Resistance, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Osteosarcoma; Quinuclidines; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |